发明名称 Cultures of trisomy 21 cytotrophoblasts for assessing risk of trisomy 21, without the need for fetal karyotyping comprises for identifying markers
摘要 Culturing cytotrophoblasts, (A), that are trisomic for human chromosome 21, or for a region of this that contains at least the gene encoding copper-zinc superoxide dismutase, after 3 days of culture, (A) express at least one peptide hormone (I) at below the mean level for normal placental cytotrophoblasts at the same stage of gestation and cultured under the same conditions, is new. Where (I) are human placental lactogen (hPL), human chorionic gonadotropin (hCG) alpha or beta human placental growth hormone (PGH) and/or leptin. Independent claims are also included for the following: (1) differential expression libraries of nucleic acid prepared from at least one culture of (A); and (2) determining the risk of trisomy 21 in a fetus.
申请公布号 FR2805824(A1) 申请公布日期 2001.09.07
申请号 FR20000002795 申请日期 2000.03.03
申请人 INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM 发明人 EVAIN BRION DANIELLE;FRENDO JEAN LOUIS
分类号 C12N5/073;C12Q1/00;G01N33/68;G01N33/74;(IPC1-7):C12N5/08 主分类号 C12N5/073
代理机构 代理人
主权项
地址